Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes

References

• BURKE, M. D., THOMPSON, S., ELCOMBE, C. R., HALPERT, J., HAAPARANTA, T. and MAYER R. T., 1985, Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology, 34, 3337–3345.
   Google Scholar
• BURKE, M. D., THOMPSON, S., WEAVER, R. J., WOLF, C. R. and MAYER, R. T., 1994, Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human liver microsomes. Biochemical Pharmacology, 48, 923–936.
   PubMed Web of Science ®Google Scholar
• BUTERS, J. T. M., SCHILLER, C. D. and Cliou, R. C., 1993, A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Biochemical Pharmacology, 46, 1577–1584.
   Google Scholar
• CHAURET, N., TREMBLAY, N., LACKMAN, R. L., GAUTHIER, J.-Y., SILVA, J. M., MAROIS, J., YERGEY, J. A. and NIC,OLL -GRIFFITH, D. A., 1999, Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Analytical Biochemistry, 276, 215–226.
   Google Scholar
• CLARKE, S. E., 1998, In vitro assessment of human cytochrome P450. Xenobiotica, 28, 1167–1202.
   PubMed Web of Science ®Google Scholar
• CONNEY, A. J., 1986, Induction of microsomal cytochrome P-450 enzymes: the first Bernard B Brodie lecture at Pennsylvania State University. Life Sciences, 39, 2493–2518.
   PubMed Web of Science ®Google Scholar
• CRESPI, C. L., MILLER, V. P. and PENMAN, B. W., 1997, Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Analytical Biochemistry, 248, 188–190.
   PubMed Web of Science ®Google Scholar
• CRESPI, C. L., MILLER, V. P. and PENMAN, B. W., 1998, High throughput screening for inhibition of cytochrome P450 metabolism. Medical Chemistry Research, 8, 457–471.
   Web of Science ®Google Scholar
• DELucA, J. G., DYSART, G. R., RASNICK, D. and BRADLEY, M. O., 1988, A direct, highly sensitive assay for cytochrome P-450 catalyzed O-deethylation using a novel coumarin analog. Biochemical Pharmacology, 37, 1731–1739.
   Web of Science ®Google Scholar
• DONATO, M. T., GômEz-LEciiON, M. J. and CASTELL, J. V., 1993, A microassay for measuring cytochrome P4501A1 and P45011B1 activities in intact human and rat hepatocytes cultured on 96-well plates. Analytical Biochemistry, 213, 29–33.
   Google Scholar
• GOmEz-LEctiON, M. J., DONATO, M. T., PONSODA, X., FABRA, R., TRULLENQUE, R. and CASTELL, J. V., 1997, Isolation, culture and use of human hepatocytes in drug research. In J. V. Casten and M. J. Gómez-LechOn (eds), In Vitro Methods in Pharmaceutical Research (London: Academic Press), pp. 129–153.
   Google Scholar
• GRASSO, P. and HINTON, R. H., 1991, Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutation Research, 248, 271–290.
   PubMed Web of Science ®Google Scholar
• GRAY, T. J. B., LAKE, B. G., BEAMAND, J. A., FOSTER, J. R. and GANGOLLI, S. D., 1983, Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicology and Pharmacology, 67, 15–25.
   Google Scholar
• JAPENGA, A. C., DAVIES, S., PRICE, R. J. and LAKE, B. G., 1993, Effect of treatment with pyrazine and some derivatives on cytochrome P450 and some enzyme activities in rat liver. Xenobiotica, 23, 169–179.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., 1987, Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism. In K. Snell and B. Mullock (eds), Biochemical Toxicology: A Practical Approach (Oxford: IRL), pp. 183–215.
   Google Scholar
• LAKE, B. G., 1995, Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annual Review of Pharmacology and Toxicology, 35, 483–507.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., 1997, In vitro methods. In R. S. McCuskey and D. L. Earnest (eds), Comprehensive Toxicology, vol. 9: Hepatic and Gastrointestinal Toxicology (Oxford: Pergamon), pp. 233–249.
   Google Scholar
• LAKE, B. G. and LEWIS, D. F. V., 1996, The CYP4 family. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 271–297.
   Google Scholar
• LAKE, B. G., RENWICK, A. B., CUNNINGHAME, M. E., PRICE, R. J., SURRY, D. and EVANS, D. C., 1998, Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicology, 131, 9–20.
   PubMed Web of Science ®Google Scholar
• LIN, J. H. and Lu, A. Y. H., 1998, Inhibition and induction of cytochrome P450 and the clinical implications. Clinical Pharmacokinetks, 35, 361–390.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FR, A. L. and RANDALL, R. J. 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• LUBET, R. A., SYI, J.-L., NELSON, J. O. and Nims, R. W., 1990, Induction of hepatic cytochrome P-450 mediated alkoxyresorufin 0-dealkylase activities in different species by prototype P-450 inducers. Chemko-Biological Interactions, 75, 325–399.
   Google Scholar
• MAUREL, P., 1996, The CYP3 family. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC Press), pp. 241–270.
   Google Scholar
• MAYER, R. T., NETTER, K. J., HEUBEL, F., HAHNEMANN, B., BUCHHEISTER, A., MAYER, G. K. and BURKE, M. D., 1990, 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases. Biochemical Pharmacology, 40, 1645–1655.
   Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   PubMedGoogle Scholar
• NERURKAR, P. V., PARK, S. S., THOMAS, P. E., Nims, R. W. and LUBET, R. A., 1993, Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolised by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochemical Pharmacology, 46, 933–943.
   PubMed Web of Science ®Google Scholar
• Nims, R. W. and LUBET, R. A., 1996, The CYP2B subfamily. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (Boca Raton: CRC press), pp. 135–160.
   Google Scholar
• Nims, R. W., DEVOR, D. E., HENNEMAN, J. R. and LUBET, R. A., 1987, Induction of alkoxyresorufin 0-dealkylases, epoxide hydrolase, and liver weight gain: correlation with tumor-promoting potential in a series of barbiturates. Carcinogenesis, 8, 67–71.
   PubMed Web of Science ®Google Scholar
• OKEY, A. B., 1990, Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics, 45, 241–298.
   PubMed Web of Science ®Google Scholar
• PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th edn (New York: McGraw-Hill) pp. 113–186.
   Google Scholar
• PELKONEN, O., MAENpAA, J., TAAVITSAINEN, P., RAUTIO, A. and RAUNIO, H., 1998, Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica, 28, 1203–1253.
   PubMed Web of Science ®Google Scholar
• PRICE, R. J., SURRY, D., RENWICK, A. B., MENESES-LORENTE, G., LAKE, B. G. and EVANS, D. C., 2000, CYP isoforrn induction screening in 96-well plates: use of 7-benzyloxy-4-trifluoromethyl-coumarin as a substrate for studies with rat hepatocytes. Xenobiotica, 30, 781–795.
   Google Scholar
• REINKE, L. A., SEXTER, S. H. and RIKANS, L. E., 1985, Comparison of ethanol and imidazole pretreatments on hepatic monooxygenase activities in the rat. Research Communications in Chemistry, Pathology and Pharmacology, 47, 97–106.
   PubMedGoogle Scholar
• RENWICK, A. B., LEWIS, D. F. V., FULFORD, S., SURRY, D., WILLIAMS, B., WORBOYS, P. D., CAI, X., WANG, R. W., PRICE, R. J., LAKE, B. G. and EVANS, D. C., 2001, Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-triliuoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Xenobiotica, 31, 187–204.
   Google Scholar
• RENWICK, A. B., SURRY, D., PRICE, R. J., LAKE, B. G. and EVANS, D. C., 2000, Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms. Xenobiotica, 30, 955–969.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., 1999, Integrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochemical Pharmacology, 57, 465–480.
   PubMed Web of Science ®Google Scholar
• SONDERFAN, A. J., ÄRLOTTO, M. P., DUTTON, M. R., MCMILLEN, S. K. and PARKINSON, A., 1987, Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P450. Archives of Biochemistry and Biophysics, 255, 27–41.
   Google Scholar
• TANAKA, E., 1998, Clinically important drug—drug interactions: role of cytochrome P450 enzymes. Journal of Clinical Pharmacology and Therapeutics, 23, 403–416.
   PubMed Web of Science ®Google Scholar
• WHITE, I. N. H., 1988, A continuous fluorimetric assay for P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin. Analytical Biochemistry, 172, 304–310.
   PubMed Web of Science ®Google Scholar
• WHYSNER, J., Ross, P. M. and WILLIAMS, G. M., 1996, Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacology and Therapeutics, 71, 153–191.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., VANDENBRANDEN, M., STEVENS, J. C., SHIPLEY, LA., RING, B. J., RETTIE, A. E. and CASHMAN, J. R., 1993, In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metabolism Reviews, 25, 453–484.
   PubMed Web of Science ®Google Scholar